SynthesisPharmacoEconomics2015
Assessing the Economics of Dengue: Results from a Systematic Review of the Literature and Expert Survey.
Synthesis in PharmacoEconomics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- A systematic review of the economic impact of rapid diagnostic tests for dengue.BMC health services research · 2017Pooled it
- Pooled it
- Global burden of dengue on healthcare systems: a meta-analysis of healthcare resource utilisation.EClinicalMedicine · 2026Article
- Article
- Forecasting Dengue: Evaluating the Role of Hydroclimate Information in Subseasonal to Seasonal Prediction.GeoHealth · 2025Article
- Perspectives and challenges in developing and implementing integrated dengue surveillance tools and technology in Thailand: a qualitative study.PLoS neglected tropical diseases · 2024Article
- Assessing the effect ofDialogues in health · 2022Article
- Cost analysis of dengue from a State in south India.The Indian journal of medical research · 2020Article
- Why vaccines matter: understanding the broader health, economic, and child development benefits of routine vaccination.Human vaccines & immunotherapeutics · 2020Article
- Transcutaneous Administration of Dengue Vaccines.Viruses · 2020Article
- Identifying the Potential Causes, Consequences, and Prevention of Communicable Diseases (Including COVID-19).BioMed research international · 2020Article
- An open challenge to advance probabilistic forecasting for dengue epidemics.Proceedings of the National Academy of Sciences of the United States of America · 2019Article
- Spatial-temporal distribution of Aedes (Stegomyia) aegypti and locations of recycling units in southeastern Brazil.Parasites & vectors · 2019Article
- A multi-country study of the economic burden of dengue fever based on patient-specific field surveys in Burkina Faso, Kenya, and Cambodia.PLoS neglected tropical diseases · 2019Article
- Infectious Disease Threats in the Twenty-First Century: Strengthening the Global Response.Frontiers in immunology · 2019Article
- The Estimates of the Health and Economic Burden of Dengue in Vietnam.Trends in parasitology · 2018Review
- An economic evaluation of vector control in the age of a dengue vaccine.PLoS neglected tropical diseases · 2017Article
- Direct cost of dengue hospitalization in Zhongshan, China: Associations with demographics, virus types and hospital accreditation.PLoS neglected tropical diseases · 2017Article
- Household Dengue Prevention Interventions, Expenditures, and Barriers to Aedes aegypti Control in Machala, Ecuador.International journal of environmental research and public health · 2017Article
- Economic report on the cost of dengue fever in Vietnam: case of a provincial hospital.ClinicoEconomics and outcomes research : CEOR · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe economics of dengue is complex and multifaceted.
objectivesWe performed a systematic review of the literature to provide a critical overview of the issues related to dengue economics research and to form a background with which to address the question of cost.
methodsThree literature databases were searched [PubMed, Embase and Latin American and Caribbean Health Sciences Literature (LILACS)], covering a period from 1980 to 2013, to identify papers meeting preset inclusion criteria. Studies were reviewed for methodological quality on the basis of a quality checklist developed for this purpose. An expert survey was designed to identify priority areas in dengue economics research and to identify gaps between the methodology and actual practice. Survey responses were combined with the literature review findings to determine stakeholder priorities in dengue economics research.
resultsThe review identified over 700 papers. Forty-two of these papers met the selection criteria. The studies that were reviewed presented results from 32 dengue-endemic countries, underscoring the importance of dengue as a global public health problem. Cost analyses were the most common, with 21 papers, followed by nine cost-effectiveness analyses and seven cost-of-illness studies, indicating a relatively strong mix of methodologies. Dengue annual overall costs (in 2010 values) ranged from US$13.5 million (in Nicaragua) to $56 million (in Malaysia), showing cost variations across countries. Little consistency exists in the way costs were estimated and dengue interventions evaluated, making generalizations around costs difficult.
conclusionsThe current evidence suggests that dengue costs are substantial because of the cost of hospital care and lost earnings. Further research in this area will broaden our understanding of the true economic impact of dengue.
Indexed as
Identifiers
26048354What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.